Form 4: AngioDynamics CEO James Clemmer Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
CEO James Clemmer disposed of 8,307 shares of AngioDynamics common stock to satisfy tax withholding obligations related to vesting restricted stock units.
Summary
- On July 19, 2024, James C. Clemmer, the President and CEO of AngioDynamics Inc., disposed of 8,307 shares of common stock.
- The disposition was an exempt transaction to cover tax withholding obligations related to the vesting of restricted stock units granted on July 19, 2023.
- The shares were disposed of at a price of $7.18 per share.
- Following the transaction, Clemmer directly owns 636,570 shares of AngioDynamics Inc.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock transactions for tax purposes. It doesn't inherently convey positive or negative sentiment about the company's performance or future prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC when company insiders, like the CEO, trade their company's stock. These filings provide transparency into insider transactions and can be monitored by investors for insights into management's perspective on the company's value and prospects.
Key Dates
| Date | Description |
|---|---|
| 07/19/2023 | Date of grant for the restricted stock units that triggered the tax obligation. |
| 07/19/2024 | Date of the stock disposal transaction. |
| 07/22/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.